CAS 17701-61-0

Propanoic acid, 3-hydroxy-2,2-dimethyl-, phenylmethyl ester

Description:

Propanoic acid, 3-hydroxy-2,2-dimethyl-, phenylmethyl ester, also known by its CAS number 17701-61-0, is an organic compound characterized by its ester functional group. This compound features a propanoic acid backbone with a hydroxyl group and two methyl groups at the second carbon, contributing to its branched structure. The presence of the phenylmethyl (benzyl) group enhances its lipophilicity, making it more soluble in organic solvents. This compound is typically a colorless to pale yellow liquid with a characteristic odor. It exhibits moderate volatility and can participate in various chemical reactions, including esterification and hydrolysis. Its molecular structure suggests potential applications in the synthesis of pharmaceuticals, agrochemicals, and as a flavoring agent due to its ester nature. Additionally, it may exhibit biological activity, which could be of interest in medicinal chemistry. Safety data should be consulted for handling and exposure guidelines, as with any chemical substance.

Formula: C₁₂H₁₆O₃

Propanoic acid, 2-(hydroxymethyl)-2-methyl-, phenylmethyl ester

CAS: 17701-61-0

Formula: C₁₂H₁₆O₃

Purity: 95%

Color and Shape: Liquid

Molecular weight: 208.2536

Ref: IN-DA002526

Benzyl 3-hydroxy-2,2-dimethylpropanoate

CAS: 17701-61-0

Benzyl 3-hydroxy-2,2-dimethylpropanoate

Purity: 95%

Molecular weight: 208.25g/mol

Ref: 54-OR93891

Benzyl 3-hydroxy-2,2-dimethylpropanoate

CAS: 17701-61-0

Formula: C₁₂H₁₆O₃

Purity: 96%

Color and Shape: Liquid, No data available.

Molecular weight: 208.257

Ref: 10-F498963

Benzyl 3-hydroxy-2,2-dimethylpropanoate

CAS: 17701-61-0

Benzyl 3-hydroxy-2,2-dimethylpropanoate is a prodrug that is metabolized to the active form, benzyl 3-hydroxy-2,2-dimethylpropionate (BZMDP), by esterases. It has been shown to have pharmacological effects in animals and humans. BZMDP is a pyrazole derivative with a carbonyl group and an alkylene chain. It binds to the human liver enzyme cytochrome P450 2C8 and inhibits the metabolism of acetaminophen, thereby increasing its bioavailability. As an analgesic agent, BZMDP has been shown to be effective against postoperative pain in animal studies. BZMDP has also been shown to reduce hyperglycemia in diabetic mice through inhibition of carbohydrate metabolism at the level of glycolysis.

Formula: C₁₂H₁₆O₃

Purity: Min. 95%

Molecular weight: 208.26 g/mol

Ref: 3D-SAA70161